Par Pharmaceutical Companies, Inc. (NYSE:PRX)

CAPS Rating: 3 out of 5

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Recs

0
Player Avatar vicres (52.90) Submitted: 7/20/2007 9:33:08 PM : Underperform Start Price: $24.60 PRX Score: -75.99

Pure speculation

Featured Broker Partners


Advertisement